FLUCYTOSINE
- Product NDC
- 59651-331
- 11-digit product format
- 596510331
- Labeler code
- 59651
- Product ID
- 59651-331_bf0234fe-1b94-44fb-a06d-86af5c5c07ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- FLUCYTOSINE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA213665
- Marketing category
- ANDA
- Marketing start
- 2020-05-01
- Substance
- FLUCYTOSINE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Nucleoside Analog Antifungal [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- FLUCYTOSINE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FLUCYTOSINE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D83282DT06 |
| Rxcui | 197702, 197703 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59651-331-01 | FLUCYTOSINE | 100 in 1 BOTTLE | CAPSULE | 100 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59651-331 | FLUCYTOSINE CAPSULE [AUROBINDO PHARMA LIMITED] | 4 | Current NDC, Legacy NDC, 1 package rows | 20220304_8b55832c-6771-4f5b-9aef-f88a1d22795e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59651-331-01 | 59651033101 | 100 CAPSULE in 1 BOTTLE (59651-331-01) | 100 capsule | 2020-05-01 | 0000-00-00 | No | No | Current |